Case Report
Successful Management of Insulin Allergy and Autoimmune Polyendocrine Syndrome Type 4 with Desensitization Therapy and Glucocorticoid Treatment: A Case Report and Review of the Literature
Table 4
Desensitization protocol using Glargine insulin.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
between injections: 20 minutes. °Administrated almost simultaneously with dosage number 14, in a different corporal region. Diameter of the flare. |